Pharmaceuticals
The companies featured on PressReleaseFinder are active in several industries.
12 Feb 2014
Healthcare market to profit from SABIC’s extended plastics portfolio, unveiled at Pharmapack 2014
SITTARD, The Netherlands, February 12, 2014 - SABIC is coming to Pharmapack Europe 2014 (Paris, February 12-13) to demonstrate its intent to further expand into the healthcare market. On Stand 354, SABIC will introduce two new pharmaceutical grades of polypropylene intended for syringes, other medical dosing application devices and also for packaging for healthcare applications. The two grades, SABIC® PP PCGR40 and a lubricated variant, SABIC® PP PCGR40L, are high-flow random copolymers typically used for producing thin-walled products with high levels of clarity.
12 Feb 2014
Clariant Healthcare Packaging promotes growing capacities and product offerings at Pharmapack Europe 2014 Paris
Muttenz, February 12, 2014 - Clariant, a world leader in specialty chemicals, represented by its business line Healthcare Packaging, will exhibit its expanding portfolio of protective packaging for pharmaceuticals at Pharmapack Europe 2014 Paris. A long time leader in pharmaceutical desiccants, oxygen scavengers and specialized container closure systems, Clariant Healthcare Packaging, along with Clariant Medical Masterbatches, will once again present its solutions to customers at PharmaPack.
Muttenz, February 12, 2014 - Clariant, a world leader in specialty chemicals, through its Healthcare Packaging business segment, has announced a partnership and collaboration with PumpArt System® for the introduction of an innovative airless dispensing technology, Tubairless®, to the pharmaceutical industry.
Muttenz, February 12, 2014 – Clariant, one of the world leaders in specialty chemicals, In the Healthcare sector, coloration of plastics plays an important role in protecting patients by identifying drug types or doses, thereby reducing the risk of errors. However, these plastic packaging materials and the colorants in them need assessment of how they behave in contact with the drug during storage and use. These extractable and leachable studies on the packaging material, play an important role in medium and high risk applications such as ocular medicines, but if something changes in the polymers or masterbatches used to manufacture the packaging, then the data from the extractable and leachable studies may no longer be valid. To address these issues Clariant has used in dedicated expertise to create a new range of standard masterbatch colors, offering the benefits of the MEVOPUR® brand, tailored to the color standard developed by the American Society of Ophthalmology. 
Muttenz, February 12, 2014 – Clariant, one of the world leaders in specialty chemicals, supports the Healthcare industry with a range of products developed for medical devices and pharmaceutical plastic packaging. With its knowledge, Clariant’s MEVOPUR® nucleant product brings improvements in the process of plastic packaging fabrication. Thanks to them the processing time can be reduced; mechanical properties improved and so companies can save time and increase the productivity. The nucleating agents used in MEVOPUR products are pre-tested using extraction protocols such as those established by US Pharmacopeia, ISO and NEW European Pharmacopeia monograph 3.1.3; the goal is helping companies to meet the challenging regulatory requirements to support “Controlled, Consistent and Compliant”.